1. Home
  2. PRTA vs EZPW Comparison

PRTA vs EZPW Comparison

Compare PRTA & EZPW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PRTA
  • EZPW
  • Stock Information
  • Founded
  • PRTA 2012
  • EZPW 1989
  • Country
  • PRTA Ireland
  • EZPW United States
  • Employees
  • PRTA N/A
  • EZPW N/A
  • Industry
  • PRTA Biotechnology: Pharmaceutical Preparations
  • EZPW Other Specialty Stores
  • Sector
  • PRTA Health Care
  • EZPW Consumer Discretionary
  • Exchange
  • PRTA Nasdaq
  • EZPW Nasdaq
  • Market Cap
  • PRTA 809.8M
  • EZPW 814.0M
  • IPO Year
  • PRTA N/A
  • EZPW 1991
  • Fundamental
  • Price
  • PRTA $6.58
  • EZPW $13.39
  • Analyst Decision
  • PRTA Buy
  • EZPW Strong Buy
  • Analyst Count
  • PRTA 9
  • EZPW 3
  • Target Price
  • PRTA $27.67
  • EZPW $19.00
  • AVG Volume (30 Days)
  • PRTA 1.7M
  • EZPW 800.2K
  • Earning Date
  • PRTA 08-07-2025
  • EZPW 07-30-2025
  • Dividend Yield
  • PRTA N/A
  • EZPW N/A
  • EPS Growth
  • PRTA N/A
  • EZPW 18.94
  • EPS
  • PRTA N/A
  • EZPW 1.19
  • Revenue
  • PRTA $137,935,000.00
  • EZPW $1,202,458,000.00
  • Revenue This Year
  • PRTA N/A
  • EZPW $9.25
  • Revenue Next Year
  • PRTA $119.20
  • EZPW $6.38
  • P/E Ratio
  • PRTA N/A
  • EZPW $11.28
  • Revenue Growth
  • PRTA 54.55
  • EZPW 8.14
  • 52 Week Low
  • PRTA $4.32
  • EZPW $9.66
  • 52 Week High
  • PRTA $25.42
  • EZPW $16.60
  • Technical
  • Relative Strength Index (RSI)
  • PRTA 59.96
  • EZPW 43.46
  • Support Level
  • PRTA $5.96
  • EZPW $13.63
  • Resistance Level
  • PRTA $6.59
  • EZPW $14.25
  • Average True Range (ATR)
  • PRTA 0.38
  • EZPW 0.35
  • MACD
  • PRTA 0.15
  • EZPW 0.05
  • Stochastic Oscillator
  • PRTA 83.93
  • EZPW 36.76

About PRTA Prothena Corporation plc

Prothena Corp PLC is a biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating rare neurodegenerative and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including psoriasis and psoriatic arthritis (PRX003) and ATTR amyloidosis (PRX004).

About EZPW EZCORP Inc. Non Voting

EZCORP Inc is a United States-based company engaged in offering pawn loans in the United States and Mexico. It also offers short-term unsecured loans and other consumer financial products, and buy and sell second-hand goods. The operating segments of the company are us Pawn, Latin America Pawn, and other international. us Pawn segment includes all pawn activities in the United States. Latin America Pawn segment includes all pawn activities in Mexico and other parts of Latin America. The company generates revenue from merchandise sales, jewelry scrapping sales, and pawn service charges, of which key revenue is derived from the merchandise sales which are primarily collateral forfeited from pawn lending operations and used merchandise purchased from the customers.

Share on Social Networks: